xanthoangelol and Staphylococcal-Infections

xanthoangelol has been researched along with Staphylococcal-Infections* in 1 studies

Other Studies

1 other study(ies) available for xanthoangelol and Staphylococcal-Infections

ArticleYear
The plant-derived chalcone Xanthoangelol targets the membrane of Gram-positive bacteria.
    Bioorganic & medicinal chemistry, 2019, 12-01, Volume: 27, Issue:23

    Xanthoangelol is a geranylated chalcone isolated from fruits of Amorpha fructicosa that exhibits antibacterial effects at low micromolar concentration against Gram-positive bacterial pathogens such as methicillin-resistant Staphylococcus aureus (MRSA), Enterococcus faecium and Enterococcus faecalis. We demonstrate that Xanthoangelol treatment of Gram-positive bacteria affects bacterial membrane integrity and leads to a leakage of intracellular metabolites. This correlates with a rapid collapse of the membrane potential and results in a fast and strong bactericidal effect. Proteomic profiling of Xanthoangelol-treated cells revealed signatures of cell wall and/or membrane damage and oxidative stress. Xanthoangelol specifically disturbs the membrane of Gram-positive bacteria potentially by forming pores resulting in cell lysis. In contrast, Xanthoangelol treatment of human cells showed only mildly hemolytic and cytotoxic effects at higher concentrations. Therefore, geranylated chalcones such as Xanthoangelol are promising lead structures for new antimicrobials against drug-resistant gram-positive pathogens.

    Topics: Anti-Bacterial Agents; Cell Line; Chalcone; Fabaceae; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections

2019